TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35270698

Group type: EXPERIMENTAL
Intervention: Regular spaghetti No 7
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Whole wheat spaghetti No 7
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High soluble fiber–low carbohydrates spaghetti No 7
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose reference
Number of subjects: 14

Group type: COMPARATOR
Intervention: White bread
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All spaghetti types
Number of subjects: 14
Study: 33059638

Group type: EXPERIMENTAL
Intervention: Mind in Labor (MIL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 30
Study: 35967116

Group type: EXPERIMENTAL
Intervention: Urgent-start peritoneal dialysis (PD)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Urgent-start temporary hemodialysis (HD)
Number of subjects: 207
Study: 32434001

Group type: EXPERIMENTAL
Intervention: Prepregnancy platelet factor 4 (third tertile vs first tertile)
Number of subjects: 1185

Group type: COMPARATOR
Intervention: Prepregnancy platelet factor 4 (third tertile vs first tertile) in placebo group
Number of subjects: 1185

Group type: COMPARATOR
Intervention: Prepregnancy platelet factor 4 (third tertile vs first tertile) in aspirin group
Number of subjects: 1185
Study: 33539149

Group type: EXPERIMENTAL
Intervention: Negative feedback condition
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Positive feedback condition
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: No feedback condition
Number of subjects: 126
Study: 32860399

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D-3 per day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 4000 mg CLA per day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D-3 and 4000 mg CLA per day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 36017026

Group type: EXPERIMENTAL
Intervention: Breathe‐Link breathing trainers with rehabilitation training for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine breathing training (Control group)
Number of subjects: 60
Study: 32345653

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Gluten-containing diet (GCD)
Number of subjects: 51
Study: 35593607

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg) + Thiocolchicoside (8 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nimesulide (100 mg)
Number of subjects: 35
Study: 33048589

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) counts/minutes
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Total sleep time
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 97
Study: 34498818

Group type: EXPERIMENTAL
Intervention: 0.6 g/kg of carbohydrate (CHO)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.6 g/kg of carbohydrate with 6 mg/kg of caffeine (CAF+CHO)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study: 36389109

Group type: COMPARATOR
Intervention: Propofol-Remifentanil (PR)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Propofol-Dexmedetomidine (PD)
Number of subjects: 200
Study: 32234083

Group type: EXPERIMENTAL
Intervention: Internet‐based personalised nutrition (PN) advice
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Conventional dietary advice (control)
Number of subjects: 1607
Study: 33371769

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe hearing difficulties
Number of subjects: 1037

Group type: EXPERIMENTAL
Intervention: Hearing devices
Number of subjects: 1037
Study: 35229960

Group type: EXPERIMENTAL
Intervention: 1 mg nicotine delivered over 1 min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.4 mg nicotine delivered over 2.5 min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 mg nicotine delivered over 5 min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 mg nicotine delivered over 10 min
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.1 mg nicotine/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.2 mg nicotine/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.4 mg nicotine/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 mg nicotine/min
Number of subjects: 24
Study: 35936870

Group type: EXPERIMENTAL
Intervention: 360-degree nature videos via head-mounted display (HMD)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 360-degree nature videos via PC screen
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control condition (listening to natural sounds without video)
Number of subjects: 36
Study: 34672468

Group type: EXPERIMENTAL
Intervention: Outpatient exercise training (ET), 30 min/d, 5 d/week, for 12 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Inpatient exercise training (ET), 30 min/d, 5 d/week, for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (conventional cardiac rehabilitation without ET), n=12
Number of subjects: 36
Study: 36326156

Group type: EXPERIMENTAL
Intervention: Packs of 20 cigarettes
Number of subjects: 236

Group type: COMPARATOR
Intervention: Packs of 25 cigarettes
Number of subjects: 236
Study: 33531268

Group type: EXPERIMENTAL
Intervention: Coban™ 2 (3M)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard care, non-compression bandaging
Number of subjects: 49
Study: 32447582

Group type: EXPERIMENTAL
Intervention: Rapeseed pod meal (RPM) at levels of 0, 20, 40, 60, 80, and 100% of dietary substrate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Roughage to concentrate (R:C) ratios of 60:40 and 40:60
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Roughage to concentrate (R:C) ratios and levels of RPM
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Increasing levels of RPM
Number of subjects: 12
Study: 35785593

Group type: EXPERIMENTAL
Intervention: Daily teriparatide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly high-dose teriparatide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisphosphonate
Number of subjects: 0
Study: 35027397

Group type: EXPERIMENTAL
Intervention: Vector vaccine ChAdOx1 nCoV-19 (Oxford-AstraZeneca)
Number of subjects: 60

Group type: COMPARATOR
Intervention: mRNA vaccine (homologous)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall seroconversion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vector vaccine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: mRNA vaccine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall newly induced humoral and/or cellular responses
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients without detectable peripheral B cells
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients with detectable peripheral B cells
Number of subjects: 60
Study: 32991493

Group type: EXPERIMENTAL
Intervention: Meyers and McKeever classification
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Various measurements of tibial spine fractures
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined Type III and IV classification
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Open reduction versus closed reduction
Number of subjects: 40
Study: 32866440

Group type: EXPERIMENTAL
Intervention: Tocilizumab 162 mg subcutaneously weekly for 48 weeks
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 210
Study: 34250845

Group type: EXPERIMENTAL
Intervention: Personality status assessment using ICD‐11 system
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: DSM‐III diagnosed patients
Number of subjects: 200
Study: 34582462

Group type: EXPERIMENTAL
Intervention: Antimicrobial (azithromycin and nitazoxanide)
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Placebo (for both interventions)
Number of subjects: 1084
Study: 616039429

Group type: EXPERIMENTAL
Intervention: Eye movement training followed by fixation training
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fixation training followed by eye movement training
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 4
Study: 35732089

Group type: EXPERIMENTAL
Intervention: Nap
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wake
Number of subjects: 40
Study: 32978539

Group type: EXPERIMENTAL
Intervention: Personalised text messaging (24 messages per week with tailored preventive advice)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Non-personalised text messaging (24 messages per week without tailored advice)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Personalised text messaging
Number of subjects: 171
Study: 33464660

Group type: EXPERIMENTAL
Intervention: 800 mg CBD
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CBD
Number of subjects: 78
Study: 33044203

Group type: EXPERIMENTAL
Intervention: Insole on less affected side during treadmill walking training (ILTW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal treadmill training (NTW)
Number of subjects: 0
Study: 34962151

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-Monitoring with Blood Glucose Meter (BGM)
Number of subjects: 0
Study: 33242924

Group type: EXPERIMENTAL
Intervention: Genetic counselling intervention (IMAGINE) with a board‐certified genetic counsellor
Number of subjects: 110

Group type: COMPARATOR
Intervention: No genetic counselling intervention (control group)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Genetic counselling intervention (IMAGINE)
Number of subjects: 110
Study: 35851700

Group type: EXPERIMENTAL
Intervention: IgE-mediated food allergy
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Non-immune-mediated reactions to food additives
Number of subjects: 541

Group type: COMPARATOR
Intervention: Oral food challenges
Number of subjects: 541
Study: 32053942

Group type: EXPERIMENTAL
Intervention: Melon concentrate (SOD B® M)
Number of subjects: 0
Study: 35385516

Group type: EXPERIMENTAL
Intervention: Women authors in computer systems research
Number of subjects: 19429

Group type: COMPARATOR
Intervention: Conference factors (size, prestige, double‐blind reviewing, inclusivity policies)
Number of subjects: 19429

Group type: COMPARATOR
Intervention: Author research experience
Number of subjects: 19429

Group type: COMPARATOR
Intervention: Author country and work sector
Number of subjects: 19429
Study: 34131726

Group type: EXPERIMENTAL
Intervention: Gavi® (semi-automated closed vitrification system)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cryotop® (manual open vitrification system)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Gavi®
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cryotop®
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Gavi® and Cryotop®
Number of subjects: 149
Study: 32423446

Group type: EXPERIMENTAL
Intervention: Art group (ATP, game-based, and music-based education)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mothers group (children received ATP and mothers received education by telephone)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (children received ATP)
Number of subjects: 200
Study: 35147767

Group type: EXPERIMENTAL
Intervention: Newer generation drug eluting stents (DES)
Number of subjects: 4953
Study: 33860793

Group type: EXPERIMENTAL
Intervention: RCTs with positive results (n=86)
Number of subjects: 238

Group type: COMPARATOR
Intervention: RCTs with negative results (n=152)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Published manuscripts
Number of subjects: 238
Study: 35843776

Group type: EXPERIMENTAL
Intervention: pembrolizumab + axitinib
Number of subjects: 861

Group type: COMPARATOR
Intervention: sunitinib
Number of subjects: 861
Study: 34394385

Group type: EXPERIMENTAL
Intervention: Ozone plus hypertonic saline 5%
Number of subjects: 34

Group type: COMPARATOR
Intervention: Hypertonic saline 5% alone
Number of subjects: 34
Study: 34935176

Group type: EXPERIMENTAL
Intervention: Semi-vegetarian high-fat diet
Number of subjects: 65
Study: 33043474

Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: ZAAD
Number of subjects: 375
Study: 35618101

Group type: EXPERIMENTAL
Intervention: 8 Gy radiotherapy
Number of subjects: 686

Group type: COMPARATOR
Intervention: 20 Gy in 5 fractions
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 686
Study: 33610419

Group type: EXPERIMENTAL
Intervention: Ultra-processed food (UPF) consumption
Number of subjects: 1485
Study: 32371038

Group type: EXPERIMENTAL
Intervention: Conventional compression factor (CCF) group (compression factor = 0.75 D)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Increased compression factor (ICF) group (extra 1.00D)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 34939897

Group type: COMPARATOR
Intervention: 6-month persistent infection (6MPI)
Number of subjects: 3025

Group type: COMPARATOR
Intervention: Oncogenic HPV types
Number of subjects: 3025
Study: 34731640

Group type: EXPERIMENTAL
Intervention: Laparoscopically-assisted vaginal hysterectomy (LAVH)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 227
Study: 33802012

Group type: EXPERIMENTAL
Intervention: HMB complex (2.4 g of HMB + 14 g of glutamine + 14 g of arginine)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (glutamine complex, 7.2 g of protein including 6 g of glutamine)
Number of subjects: 49
Study: 32474920

Group type: EXPERIMENTAL
Intervention: SNP rs1165196 on SLC17A1
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: weighted genetic risk score (wGRS)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis using SNP rs1165196
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis using wGRS
Number of subjects: 633
Study: 37650921

Group type: EXPERIMENTAL
Intervention: Curcumin (1 g) with piperine (5 mg) twice daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 33498854

Group type: EXPERIMENTAL
Intervention: Full prognostic index
Number of subjects: 7042

Group type: COMPARATOR
Intervention: Simplified risk score at diagnosis
Number of subjects: 7042
Study: 32112718

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Reciprocating microsaw
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional burrs
Number of subjects: 80
Study: 36177965

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery using Preceyes Surgical System (PSS)
Number of subjects: 15
Study: 34374430

Group type: EXPERIMENTAL
Intervention: Mammography decision aid (DA)
Number of subjects: 283
Study: 32235946

Group type: EXPERIMENTAL
Intervention: Customized group vestibular rehabilitation (1 h 30 min, once a week, supervised)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cawthorne‐Cooksey exercises and simple balance exercises (15 min, twice a day, unsupervised)
Number of subjects: 58
Study: 36732096

Group type: EXPERIMENTAL
Intervention: Lung ultrasound score (LUSsc)
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: LUSsc cut-off point of 8 for <32+0 weeks group
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: LUSsc cut-off point of 7 for 32+0‐36+6 weeks group
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Validation results for <32+0 weeks group
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Validation results for 32+0‐36+6 weeks group
Number of subjects: 857
Study: 34477816

Group type: EXPERIMENTAL
Intervention: CT-P10
Number of subjects: 140

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 140
Study: 35309222

Group type: EXPERIMENTAL
Intervention: CDIO training model
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional training method
Number of subjects: 38
Study: 33866270

Group type: EXPERIMENTAL
Intervention: Group A: TV 6 ml/kg, PEEP 5 cmH20
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Group B: TV 6 ml/kg, PEEP 8 cmH20
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Group C: TV 8 ml/kg, PEEP 5 cmH20
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Group D: TV 8 ml/kg, PEEP 8 cmH20
Number of subjects: 25
Study: 32690492

Group type: EXPERIMENTAL
Intervention: Assisted hatching (AH) on warmed blastocysts before embryo transfer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no assisted hatching)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 0
Study: 35022661

Group type: EXPERIMENTAL
Intervention: Group- plus home-based Tai Chi program
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 98
Study: 34760067

Group type: EXPERIMENTAL
Intervention: Kedo-SG blue pediatric rotary files
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Kedo-SH pediatric hand files
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Reciprocating hand K-files
Number of subjects: 45

Group type: COMPARATOR
Intervention: All groups (Kedo-SG blue, Kedo-SH, reciprocating hand K-files)
Number of subjects: 45
Study: 33141834

Group type: EXPERIMENTAL
Intervention: Literacy-sensitive action plan
Number of subjects: 1769

Group type: COMPARATOR
Intervention: Standard action plan
Number of subjects: 1769

Group type: COMPARATOR
Intervention: Allocation method (random, health literacy screening, participant selection)
Number of subjects: 1769
Study: 33949001

Group type: EXPERIMENTAL
Intervention: r‐ATG 2.5 mg/kg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: r‐ATG 3.5 mg/kg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Higher r‐ATG concentration (day 14)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Higher r‐ATG concentration (day 28)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Higher r‐ATG concentrations at day 28
Number of subjects: 81
Study: 35033547

Group type: EXPERIMENTAL
Intervention: Specific balance training
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comprehensive balance training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 33284903

Group type: COMPARATOR
Intervention: 0.5% sodium hypochlorite (positive control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dettol liquid soap
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lifebuoy liquid soap
Number of subjects: 28

Group type: COMPARATOR
Intervention: Phosphate-buffered saline solution (negative control)
Number of subjects: 28
Study: 36412376

Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT) for 30 min in seated position using Xbox-Kinect, 3 days/week for 4 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional therapy for 30 min, 3 days/week for 4 weeks
Number of subjects: 21
Study: 32008198

Group type: EXPERIMENTAL
Intervention: Resistant starch (RS) supplementation (16 g RS/day)
Number of subjects: 16
Study: 33550845

Group type: EXPERIMENTAL
Intervention: Multidisciplinary Team (MDT) approach
Number of subjects: 490

Group type: COMPARATOR
Intervention: Traditional screening approach
Number of subjects: 490
Study: 35459118

Group type: EXPERIMENTAL
Intervention: PEERS® (n = 54)
Number of subjects: 106

Group type: COMPARATOR
Intervention: ROAD (n = 52)
Number of subjects: 106
Study: 32313980

Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Clonidine (0.150 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 35948873

Group type: EXPERIMENTAL
Intervention: REACH intervention (text message‐delivered self‐management support focusing on medication adherence, diet, and exercise)
Number of subjects: 506
Study: 33276298

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic use in neonatal lambs
Number of subjects: 133
Study: 32151119

Group type: EXPERIMENTAL
Intervention: Oral/enteral nutrition plus pantoprazole
Number of subjects: 300

Group type: COMPARATOR
Intervention: Oral/enteral nutrition only
Number of subjects: 300
Study: 35460853

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SFA puncture (p-group)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Traditional SFA cutdown (c-group)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Comparison of time management for vascular access
Number of subjects: 107

Group type: COMPARATOR
Intervention: Anesthesia administered
Number of subjects: 107

Group type: COMPARATOR
Intervention: Complications within 3 months
Number of subjects: 107
Study: 32522414

Group type: EXPERIMENTAL
Intervention: 0.1‐mL ID injection of purified Vero cell rabies vaccine (PVRV) on days 0 and 28
Number of subjects: 49

Group type: COMPARATOR
Intervention: 0.5‐mL intramuscular PVRV on D0, D7 and D28
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: JE‐CV subcutaneously on D0 and D365
Number of subjects: 49
Study: 36184275

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) infusion following hysteroscopic adhesiolysis
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (only intrauterine-suitable balloon)
Number of subjects: 123
Study: 34579104

Group type: EXPERIMENTAL
Intervention: 800 mg of EGCG and 60 mL of coconut oil
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 32001194

Group type: EXPERIMENTAL
Intervention: MERS-CoV outbreak impact on psychological distress
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Perceived sufficiency of information
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sources of information
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-reported hygienic habits and social avoidance
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Accessed resources
Number of subjects: 200
Study: 32996349

Group type: COMPARATOR
Intervention: Control group (routine practice pattern)
Number of subjects: 164
Study: 33028555

Group type: EXPERIMENTAL
Intervention: Varenicline and nicotine replacement therapy (NRT) lozenges
Number of subjects: 0

Group type: COMPARATOR
Intervention: Varenicline and placebo lozenges
Number of subjects: 0
Study: 35254390

Group type: EXPERIMENTAL
Intervention: Intensive SBP target less than 120 mm Hg
Number of subjects: 547

Group type: COMPARATOR
Intervention: Standard SBP target less than 140 mm Hg
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Between-group comparison
Number of subjects: 547